BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee HY, Oh H, Park CH, Yeo YH, Nguyen MH, Jun DW. Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis. World J Gastroenterol 2019; 25(23): 2961-2972 [PMID: 31249453 DOI: 10.3748/wjg.v25.i23.2961]
URL: https://www.wjgnet.com/1007-9327/full/v25/i23/2961.htm
Number Citing Articles
1
HeeKyoung Choi, Gi Hyeon Seo. Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naïve Chronic Hepatitis B Patients in KoreaJournal of Korean Medical Science 2021; 36(14) doi: 10.3346/jkms.2021.36.e89
2
Jin Shang, Huan Liu, Qin Wen, Rili M ise, You Tu, Lang Bai, Hong Tang. Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancyInternational Journal of Infectious Diseases 2021; 105: 626 doi: 10.1016/j.ijid.2021.03.023
3
Ramesh Kumar, Rajeev Nayan Priyadarshi, Utpal Anand. Chronic renal dysfunction in cirrhosis: A new frontier in hepatologyWorld Journal of Gastroenterology 2021; 27(11): 990-1005 doi: 10.3748/wjg.v27.i11.990
4
Norio Itokawa, Masanori Atsukawa, Akihito Tsubota, Koichi Takaguchi, Makoto Nakamuta, Atsushi Hiraoka, Keizo Kato, Hiroshi Abe, Shigeru Mikami, Noritomo Shimada, Makoto Chuma, Akito Nozaki, Haruki Uojima, Chikara Ogawa, Toru Asano, Joji Tani, Asahiro Morishita, Tomonori Senoh, Naoki Yamashita, Tsunekazu Oikawa, Yoshihiro Matsumoto, Mai Koeda, Yuji Yoshida, Tomohide Tanabe, Tomomi Okubo, Taeang Arai, Korenobu Hayama, Ai‐Nakagawa Iwashita, Chisa Kondo, Toshifumi Tada, Hidenori Toyoda, Takashi Kumada, Katsuhiko Iwakiri. Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B JGH Open 2021; 5(1): 34 doi: 10.1002/jgh3.12443